NinePointTwo Capital »

Tg Therapeutics shares owned by NinePointTwo Capital

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by NinePointTwo Capital from 13F filings

Historical chart of NinePointTwo Capital investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by NinePointTwo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by NinePointTwo Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $669k 39k 17.08
2023-06-30 $252k 10k 24.78
2023-03-31 $208k 14k 14.98

More positions owned by NinePointTwo Capital

Schwab Strategic Tr Us Tips Etf (SCHP)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Ishares Tr Tips Bd Etf (TIP)
Dbx Etf Tr Xtrack Usd High (HYLB)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Ishares Tr Select Divid Etf (DVY)
Apollo Global Mgmt (APO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Apple (AAPL)
Hca Holdings (HCA)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Nxp Semiconductors N V (NXPI)

View all positions for NinePointTwo Capital

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Pictet Asset Management Holding SA
Geode Capital Management
Woodline Partners
Goldman Sachs Group
Soleus Capital Management
Susquehanna International
Opaleye Management
Nuveen Asset Management
Deep Track Capital
Bank of America Corporation
Hood River Capital Management
Northern Trust

View all funds holding Tg Therapeutics